PERCEPTIVE ADVISORS LLC Insider Trading $VBIV VBI Vaccines Inc/BC
Get free email notifications about insider trading for PERCEPTIVE ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERCEPTIVE ADVISORS LLC. PERCEPTIVE ADVISORS LLC is 10% Owner in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in VBI VACCINES INC. ($VBIV) and in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in SCYNEXIS INC ($SCYX) and in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in Athenex, Inc. ($ATNX) and 10% Owner in ALBIREO PHARMA, INC. ($ALBO) and Director in Lyra Therapeutics, Inc. ($LYRA) and 10% Owner in VBI Vaccines Inc/BC ($VBIV) and 10% Owner in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in ADMA BIOLOGICS, INC. ($ADMA) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in ACELRX PHARMACEUTICALS INC ($ACRX) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and 10% Owner in LEAP THERAPEUTICS, INC. ($LPTX) and 10% Owner in Versartis, Inc. ($VSAR) and in Kadmon Holdings, Inc. ($KDMN) and 10% Owner in Menlo Therapeutics Inc. ($MNLO) and 10% Owner in Corium International, Inc. ($CORI) and 10% Owner in Quotient Ltd ($QTNT) and 10% Owner in Athira Pharma, Inc. ($ATHA) and Director in Athira Pharma, Inc. ($ATHA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Verrica Pharmaceuticals Inc. ($VRCA) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Dova Pharmaceuticals, Inc. ($DOVA) and 10% Owner in Motus GI Holdings, Inc. ($MOTS) and 10% Owner in Prometheus Biosciences, Inc. ($RXDX) and 10% Owner in Rain Therapeutics Inc. ($RAIN) and Director in Solid Biosciences Inc. ($SLDB) and Director in MeiraGTx Holdings plc ($MGTX) and Director in Landos Biopharma, Inc. ($LABP) and Director in ARYA Sciences Acquisition Corp II ($ARYB).
PERCEPTIVE ADVISORS LLC in VBI Vaccines Inc/BC
Trading Symbol: VBIVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 55,042,456 shares
Latest Transaction: Apr 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PERCEPTIVE ADVISORS LLC in VBI Vaccines Inc/BC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRX, ADMA, AGRX, ALBO, ALDX, FOLD, ARAV, ATNX, ATHA, CATB, CERE, CORI, CRNX, DOVA, GBT, KDMN, LJPC, LABP, LPTX, LYRA, MGTX, MOTS, RXDX, QTNT, RAIN, SCYX, SLDB, VBIV, VBIV, VRCA, MNLO, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 28 2020 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.10 | 9,090,909 | 10,000,000 | 55,042,456 | 46 M to 55 M (+19.78 %) |
Sep 24 2019 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.50 | 20,000,000 | 10,000,000 | 45,951,556 | 26 M to 46 M (+77.07 %) |
Jun 20 2019 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.65 | 1,000,000 | 650,000 | 25,951,556 | 25 M to 26 M (+4.01 %) |
Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.62 | 1,000,000 | 618,000 | 24,951,556 | 24 M to 25 M (+4.18 %) |
Dec 17 2018 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.40 | 14,285,714 | 20,000,000 | 23,631,439 | 9.3 M to 23.6 M (+152.86 %) |
Oct 30 2017 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.05 | 3,100,000 | 9,455,000 | 9,345,725 | 6.2 M to 9.3 M (+49.63 %) |
Page: 1